Strain typing and antimicrobial resistance of fluoroquinolone-resistant Neisseria gonorrhoeae causing a California infection outbreak

Journal of Clinical Microbiology

Volumn 47, Issue 9, 2009, Pages 2944-2949

  Morris, Sheldon R ^a,d   Moore, Douglas F ^b   Hannah, Paul B ^b   Wang, Susan A ^c   Wolfe, Julia ^b   Trees, David L ^c   Bolan, Gail ^a   Bauer, Heidi M ^a  

^a CALIFORNIA DEPARTMENT OF PUBLIC HEALTH   (United States)

^b Orange County Public Health Laboratory   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CEFIXIME; CEFTRIAXONE; CIPROFLOXACIN; OFLOXACIN; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPECTINOMYCIN; TETRACYCLINE DERIVATIVE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CLINICAL ARTICLE; EPIDEMIC; GONORRHEA; HUMAN; MALE; NEISSERIA GONORRHOEAE; NONHUMAN; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SEROTYPE; UNITED STATES;

ADOLESCENT; ADULT; AMINO ACIDS; ANTI-BACTERIAL AGENTS; BACTERIAL TYPING TECHNIQUES; CALIFORNIA; CLUSTER ANALYSIS; DISEASE OUTBREAKS; DNA GYRASE; DNA TOPOISOMERASE IV; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; FLUOROQUINOLONES; GENOTYPE; GONORRHEA; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; NEISSERIA GONORRHOEAE; PHENOTYPE; SEROTYPING; STATISTICS AS TOPIC; YOUNG ADULT;

NEISSERIA GONORRHOEAE;

EID: 69949105391     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01001-09     Document Type: Article

References (36)

1. Bauer, H. M., K. E. Mark, M. Samuel, S. A. Wang, P. Weismuller, D. Moore, R. A. Gunn, C. Peter, A. Vannier, N. DeAugustine, J. D. Klausner, J. S. Knapp, and G. Bolan. 2005. Prevalence of and associated risk factors for fluoroquinolone-resistant Neisseria gonorrhoeae in California, 2000-2003. Clin. Infect. Dis. 41:795-803.
2. California Department of Health Services Sexually Transmitted Disease Control Branch. 2006, posting date. Sexually transmitted diseases in California, 2005. California Department of Health Services Sexually Transmitted Disease Control Branch, Richmond.
3. California Department of Health Services Sexually Transmitted Disease Control Branch. 2006, posting date. California gonorrhea treatment guidelines. California Department of Health Services Sexually Transmitted Disease Control Branch, Richmond.
4. Centers for Disease Control and Prevention. 2008. Availability of cefixime 400 mg tablets - United States, April 2008. MMWR Morb. Mortal. Wkly. Rep. 57:435.
5. Centers for Disease Control and Prevention. 2000. Fluoroquinolone- resistance in Neisseria gonorrhoeae, Hawaii, 1999, and decreased susceptibility to azithromycin in N. gonorrhoeae, Missouri, 1999. MMWR Morb. Mortal. Wkly. Rep. 49:833-837.
6. Centers for Disease Control and Prevention. 2007. Increases in gonorrhea- eight western states, 2000-2005. MMWR Morb. Mortal. Wkly. Rep. 56:222-225.
7. Centers for Disease Control and Prevention. 2006. Notice to readers: discontinuation of spectinomycin. MMWR Morb. Mortal. Wkly. Rep. 55:370.
8. Centers for Disease Control and Prevention. 2003. PulseNet BioNumerice version 2.5 training manual. Centers for Disease Control and Prevention Atlanta, GA.
9. Centers for Disease Control and Prevention. 2006. Sexually transmitted diseases treatment guidelines, 2006. MMWR Recommend. Rep. 55(No.):42-49.
10. Centers for Disease Control and Prevention. 2007. Update to CDC's sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections. MMWR Morb. Mortal. Wkly. Rep. 56:332-336.
11. Clinical and Laboratory Standards Institute. 2008. Performance standards for antimicrobial susceptibility testing; 18th informational supplement Clinical and Laboratory Standards Institute, Wayne, PA.
12. Donegan, E. A., D. N. Wirawan, P. Muliawan, J. Schachter, J. Moncada, M. Parekh, and J. S. Knapp. 2006. Fluoroquinolone-resistant Neisseria gonorrhoeae in Bali, Indonesia: 2004. Sex. Transm. Dis. 33:625-629.
13. Greco, V., L. K. Ng, R. Catana, H. Li, and J. A. Dillon. 2003. Molecular epidemiology of Neisseria gonorrheae isolates with plasmid-mediated tetracycline resistance in Canada: temporal and geographical trends (1986-1997). Microb. Drug Resist. 9:353-360.
14. Knapp, J. S., J. A. Hale, S. W. Neal, K. Wintersheid, R. J. Rice, and W. L. Whittington. 1995. Proposed criteria for interpretation of susceptibilities of strains of Neisseria gonorrhoeae to ciprofloxacin, ofloxacin, enoxacin, lomefloxacin, and norfloxacin. Antimicrob. Agents Chemother. 39:2442-2445.
15. Knapp, J. S., K. K. Holmes, P. Bonin, and E. W. Hook. 1987. Epidemiology of gonorrhea: distribution and temporal changes in auxotype/serovar classes of Neisseria gonorrhoeae. Sex. Transm. Dis. 14:26-32.
16. Knapp, J. S., M. R. Tam, R. C. Nowinski, K. K. Holmes, and E. G. Sandstrom. 1984. Serological classification of Neisseria gonorrhoeae with use of monoclonal antibodies to gonococcal outer membrane protein I. J. Infect. Dis. 150:44-48.
17. McLean, C. A., S. A. Wang, G. L. Hoff, L. Y. Dennis, D. L. Trees, J. S. Knapp, L. E. Markowitz, and W. C. Levine. 2004. The emergence of Neisseria gonorrhoeae with decreased susceptibility to azithromycin in Kansas City, Missouri, 1999 to 2000. Sex. Transm. Dis. 31:73-78.
18. Morris, S. R., J. S. Knapp, D. F. Moore, D. L. Trees, S. A. Wang, G. Bolan, and H. M. Bauer. 2008. Using strain typing to characterise a fluoroquinolone- resistant Neisseria gonorrhoeae transmission network in Southern California. Sex. Transm. Infect. 84:290-291.
19. National Committee for Clinical Laboratory Standards. 1993. Approved standard M7-A3. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. National Committee for the Clinical Laboratory Standards, Wayne, PA.
20. Ng, L. K., P. Sawatzky, I. E. Martin, and S. Booth. 2002. Characterization of ciprofloxacin resistance in Neisseria gonorrhoeae isolates in Canada. Sex. Transm. Dis. 29:780-788.
21. Ota, K. V., F. Jamieson, D. N. Fisman, K. E. Jones, I. E. Tamari, L. K. Ng, L. Towns, P. Rawte, A. Di Prima, T. Wong, and S. E. Richardson. 2009. Prevalence of and risk factors for quinolone-resistant Neisseria gonorrhoeae infection in Ontario. Can. Med. Assoc. J. 180:287-290.
22. Schwarcz, S. K., J. M. Zenilman, D. Schnell, J. S. Knapp, E. W. Hook III, S. Thompson, F. N. Judson, K. K. Holmes, et al. 1990. National surveillance of antimicrobial resistance in Neisseria gonorrhoeae. JAMA 264:1413-1417. (Pubitemid 20331936)
23. Short, H. B., V. B. Ploscowe, J. A. Weiss, and F. E. Young. 1977. Rapid method for auxotyping multiple strains of Neisseria gonorrhoeae. J. Clin. Microbiol. 6:244-248.
24. Sosa, J., S. Ramirez-Arcos, M. Ruben, H. Li, R. Llanes, A. Llop, and J. A. Dillon. 2003. High percentages of resistance to tetracycline and penicillin and reduced susceptibility to azithromycin characterize the majority of strain types of Neisseria gonorrhoeae isolates in Cuba, 1995-1998. Sex. Transm. Dis. 30:443-448.
25. Tapsall, J. 2009. Multidrug-resistant Neisseria gonorrhoeae. Can. Med. Assoc. J. 180:268-269.
26. Tapsall, J. W. 2005. Antibiotic resistance in Neisseria gonorrhoeae. Clin. Infect. Dis. 41(Suppl. 4):S263-S268.
27. Tapsall, J. W., T. R. Shultz, E. A. Limnios, B. Donovan, G. Lum, and B. P. Mulhall. 1998. Failure of azithromycin therapy in gonorrhea and discorrelation with laboratory test parameters. Sex. Transm. Dis. 25:505-508.
28. Trees, D. L., A. J. Schultz, and J. S. Knapp. 2000. Use of the neisserial lipoprotein (Lip) for subtyping Neisseria gonorrhoeae. J. Clin. Microbiol. 38:2914-2916.
29. Wang, S. A., A. B. Harvey, S. M. Conner, A. A. Zaidi, J. S. Knapp, W. L. Whittington, C. del Rio, F. N. Judson, and K. K. Holmes. 2007. Antimicrobial resistance for Neisseria gonorrhoeae in the United States, 1988 to 2003: the spread of fluoroquinolone resistance. Ann. Intern. Med. 147:81-88.
30. Wang, S. A., M. V. Lee, N. O'Connor, C. J. Iverson, R. G. Ohye, P. M. Whiticar, J. A. Hale, D. L. Trees, J. S. Knapp, P. V. Effler, and H. S. Weinstock. 2003. Multidrug-resistant Neisseria gonorrhoeae with decreased susceptibility to cefixime-Hawaii, 2001. Clin. Infect. Dis. 37:849-852.
31. Weinstock, H., D. Trees, and J. Papp. 2008. Antimicrobial resistance to sexually transmitted infections. In I. W. Fong and K. Drlica (ed.), Antimicrobial resistance and implications for the twenty-first century. Springer, Berlin, Germany.
32. Whittington, W. L., and J. S. Knapp. 1988. Trends in resistance of Neisseria gonorrhoeae to antimicrobial agents in the United States. Sex. Transm. Dis. 15:202-210.
33. Workowski, K. A., S. M. Berman, and J. M. Douglas, Jr. 2008. Emerging antimicrobial resistance in Neisseria gonorrhoeae: urgent need to strengthen prevention strategies. Ann. Intern. Med. 148:606-613.
34. Xia, M., M. C. Roberts, W. L. Whittington, K. K. Holmes, J. S. Knapp, J. A. Dillon, and T. Wi. 1996. Neisseria gonorrhoeae with decreased susceptibility to ciprofloxacin: pulsed-field gel electrophoresis typing of strains from North America, Hawaii, and the Philippines. Antimicrob. Agents Chemother. 40:2439-2440.
35. Xia, M., W. L. Whittington, K. K. Holmes, F. A. Plummer, and M. C. Roberts. 1995. Pulsed-field gel electrophoresis for genomic analysis of Neisseria gonorrhoeae. J. Infect. Dis. 171:455-458.
36. Yokoi, S., T. Deguchi, T. Ozawa, M. Yasuda, S. Ito, Y. Kubota, M. Tamaki, and S. Maeda. 2007. Threat to cefixime treatment for gonorrhea. Emerg. Infect. Dis. 13:1275-1277.